Curis
CRIS
#10294
Rank
A$16.67 M
Marketcap
A$1.29
Share price
-1.39%
Change (1 day)
-77.49%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): A-$5.79

According to Curis's latest financial reports the company's current EPS (TTM) is A-$5.27. In 2024 the company made an earnings per share (EPS) of A-$10.10 an increase over its 2023 EPS that were of A-$12.97.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.79-42.67%
2024A-$10.10-22.15%
2023A-$12.97-26.17%
2022A-$17.5622.3%
2021A-$14.36-25.37%
2020A-$19.24-30.93%
2019A-$27.86-2.02%
2018A-$28.43
2016A-$64.62-10%
2015A-$71.80138.1%
2014A-$30.1640%
2013A-$21.54-25%
2012A-$28.7266.67%
2011A-$17.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$2.47-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.26-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.52-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$3.42-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$4.85-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$16.14 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$2.02-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA